Larson PJ - Search Results

1

Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects.

Schwartz JI, Dallob AL, Larson PJ, Laterza OF, Miller J, Royalty J, Snyder KM, Chappell DL, Hilliard DA, Flynn ME, Cavanaugh PF Jr, Wagner JA. Schwartz JI, et al. Among authors: larson pj. J Clin Pharmacol. 2008 Jun;48(6):745-54. doi: 10.1177/0091270008317590. Epub 2008 Apr 23. J Clin Pharmacol. 2008. PMID: 18434566 Clinical Trial.

2

The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.

Schwartz J, Hunt T, Smith WB, Wong P, Larson P, Crumley T, Mehta A, Gottesdiener K, Agrawal N. Schwartz J, et al. J Clin Pharmacol. 2009 Jul;49(7):807-15. doi: 10.1177/0091270009337131. Epub 2009 May 14. J Clin Pharmacol. 2009. PMID: 19443681 Clinical Trial.

3

Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects.

Lauring B, Dishy V, Luo WL, Laterza O, Patterson J, Cote J, Chao A, Larson P, Gutierrez M, Wagner JA, Lai E. Lauring B, et al. J Clin Pharmacol. 2009 Dec;49(12):1426-35. doi: 10.1177/0091270009339593. Epub 2009 Oct 15. J Clin Pharmacol. 2009. PMID: 19833861 Clinical Trial.

4

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, does not affect the pharmacokinetics of ethinyl estradiol or norethindrone in healthy female subjects.

Migoya E, Larson P, Bergman A, Miller J, Johnson-Levonas AO, Lasseter KC, Wagner JA. Migoya E, et al. J Clin Pharmacol. 2011 Sep;51(9):1319-25. doi: 10.1177/0091270010381497. Epub 2011 Jan 5. J Clin Pharmacol. 2011. PMID: 21209231 Clinical Trial.

5

Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers.

Schwartz JI, De Smet M, Larson PJ, Verbesselt R, Ebel DL, Lins R, Lens S, Porras AG, Gertz BJ. Schwartz JI, et al. Among authors: larson pj. J Clin Pharmacol. 2001 Jan;41(1):107-12. doi: 10.1177/00912700122009755. J Clin Pharmacol. 2001. PMID: 11144988 Clinical Trial.

6

An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe.

Bachmann K, White D, Jauregui L, Schwartz JI, Agrawal NG, Mazenko R, Larson PJ, Porras AG. Bachmann K, et al. Among authors: larson pj. J Clin Pharmacol. 2003 Oct;43(10):1082-90. doi: 10.1177/0091270003257454. J Clin Pharmacol. 2003. PMID: 14517190 Clinical Trial.

7

Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males.

Herman GA, Mistry GC, Yi B, Bergman AJ, Wang AQ, Zeng W, Chen L, Snyder K, Ruckle JL, Larson PJ, Davies MJ, Langdon RB, Gottesdiener KM, Wagner JA. Herman GA, et al. Among authors: larson pj. Br J Clin Pharmacol. 2011 Mar;71(3):429-36. doi: 10.1111/j.1365-2125.2010.03852.x. Br J Clin Pharmacol. 2011. PMID: 21284702 Free PMC article. Clinical Trial.

8

Single therapeutic and supratherapeutic doses of anacetrapib, a cholesteryl ester transfer protein inhibitor, do not prolong the QTcF interval in healthy volunteers.

Lauring B, Liu Y, Li XS, Larson P, Moreau A, Farmer HF, Johnson-Levonas AO, Wagner JA, Lai E. Lauring B, et al. J Clin Pharmacol. 2014 Jul;54(7):765-75. doi: 10.1002/jcph.278. Epub 2014 Mar 6. J Clin Pharmacol. 2014. PMID: 24615657 Clinical Trial.

9

Effect of a single cyclosporine dose on the single-dose pharmacokinetics of sitagliptin (MK-0431), a dipeptidyl peptidase-4 inhibitor, in healthy male subjects.

Krishna R, Bergman A, Larson P, Cote J, Lasseter K, Dilzer S, Wang A, Zeng W, Chen L, Wagner J, Herman G. Krishna R, et al. J Clin Pharmacol. 2007 Feb;47(2):165-74. doi: 10.1177/0091270006296523. J Clin Pharmacol. 2007. PMID: 17244767 Clinical Trial.

10

The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.

Schwartz JI, Bugianesi KJ, Ebel DL, De Smet M, Haesen R, Larson PJ, Ko A, Verbesselt R, Hunt TL, Lins R, Lens S, Porras AG, Dieck J, Keymeulen B, Gertz BJ. Schwartz JI, et al. Among authors: larson pj. Clin Pharmacol Ther. 2000 Dec;68(6):626-36. doi: 10.1067/mcp.2000.112244. Clin Pharmacol Ther. 2000. PMID: 11180023 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters